2005 announcements

DateTitle
23/12/2005 Demerger of Mayne Pharma - Communication with shareholders
20/12/2005 Appendix 3B.
19/12/2005 Appendix 3Y x 4
14/12/2005 Notification of Changes.
13/12/2005 Consumer site visit
13/12/2005 Pathology site visit
13/12/2005 MYP & SYB - CGT Cost Bases
07/12/2005 Form 604 Notice of change of interests of substantial holder
02/12/2005 Form 603 Notice of initial substantial holder
01/12/2005 Symbion Health acquires Mansfield Pathology
01/12/2005 Final Share Buy-Back Notice
30/11/2005 Form 604 Notice of change of interests of substantial holder
28/11/2005 Appendix 3Y - Change of Director's Interest Notice
28/11/2005 Appendix 3Y - Change of Director's Interest Notice
28/11/2005 Appendix 3X - Initial Director's Interest Notice
28/11/2005 Appendix 3B - new issue announcement
25/11/2005 Appendix 3Z
25/11/2005 Appendix 3B - new issue announcement
25/11/2005 Appendix 3Z
25/11/2005 Appendix 3Y- change in director's interest notice
25/11/2005 Appendix 3Z
25/11/2005 Appendix 3Z
25/11/2005 Appendix 3Z
21/11/2005 Introduction to Symbion Health
18/11/2005 Court approves Mayne demerger
16/11/2005 2005 EGM Presentation Slides
16/11/2005 2005 EGM Chairman's speech
16/11/2005 Demerger Scheme Meetings - Results of Meetings
15/11/2005 Appendix 3Y
14/11/2005 Appendix 3Y - change in director's interest notice
11/11/2005 Mayne prepares to defend NSW Payroll tax claim
10/11/2005 CEO Elect on Mayne Pharma
09/11/2005 Mayne welcomes continued certainty for community pharmacy
08/11/2005 AGM 2005 Chairmans address to shareholders
08/11/2005 AGM 2005 Group Managing Directors address to shareholders
08/11/2005 AGM 2005 Results of Meeting
08/11/2005 Mayne Group Limited Annual General Meeting 2005
03/11/2005 Mayne Receives US Court Judgement For Propofol
02/11/2005 Webcast of Annual General Meeting on 8 November 2005
18/10/2005 Appendix 3Y - change in director's interest notice
18/10/2005 Appendix 3Y - change in director's interest notice
14/10/2005 Appendix 3Y - change in director's interest notice
12/10/2005 Appendix 3Y - change in director's interest notice
10/10/2005 Proposed demerger of Mayne Pharma - Speech
10/10/2005 Explanatory Memorandum for Mayne Pharma Demerger
10/10/2005 Mayne releases Explanatory Memorandum for Shareholders
10/10/2005 Proposed demerger of Mayne Pharma Limited - presentation
07/10/2005 Annual Review 2005
07/10/2005 Financial Report 2005
07/10/2005 Notice of 2005 Annual General Meeting
05/10/2005 Appendix 3B - New issue announcement
03/10/2005 Appendix 3Y - Change of director's interest notice
23/09/2005 Mayne Lodges Explanatory Memorandum with ASIC and Proceeds With Proposed Demerger
12/09/2005 Annual Review and Full Financial Report 2005
12/09/2005 Annual Review 2005
12/09/2005 Financial Report 2005
12/09/2005 Appendix 3B - New issue announcement
06/09/2005 Dividend Reinvestment Plan - Share Price
31/08/2005 Mayne Pharma Announces New CEO Appointment
29/08/2005 Appendix 3B - New issue announcement
24/08/2005 Mayne reports healthy increase in full year EBIT
24/08/2005 Preliminary Final Report - Financial Year ended 30 June 2005
24/08/2005 2005 Full year results presentation
18/08/2005 Appendix 3Y - Change of Director's Interest Notice
17/08/2005 Mayne full year results webcast on 24 August 2005
09/08/2005 Mayne Announces Domestic Business CEO Appointment
05/08/2005 Mayne receives Australian court decision for Epirubicin
04/07/2005 Appendix 3X - Initial Director's Interest Notice
04/07/2005 Options expiring various dates & exercisable at various prices
01/07/2005 Mayne Pharma provides strategic update
28/06/2005 Mayne appoints non-executive director
17/06/2005 Update regarding proposed demerger
16/06/2005 Appendix 3X - Initial Director's Interest Notice (x 2)
08/06/2005 Mayne announces Board appointments
03/06/2005 Form 484 - Cancellation of shares
12/05/2005 Share buy-back
04/05/2005 Mayne to assess merits of demerger
18/04/2005 Paclitaxel update
06/04/2005 Options expiring various dates & exercisable at various prices
01/04/2005 Appendix 3Z - Final Director's Interest Notice
31/03/2005 Appendix 3Y - Change of Director's Interest Notice
31/03/2005 Appendix 3B - Dividend Reinvestment Plan
23/03/2005 Appendix 3F - Final Share Buy-Back Notice
23/03/2005 Form 484 - Cancellation of shares
21/03/2005 Retirement of Non-Executive Director
18/03/2005 Appendix 3Y - Change of Director's Interest Notice (x 6)
10/03/2005 Dividend Reinvestment Plan - Share Price
10/03/2005 Citigroup Annual Investment Conference presentation slides
09/03/2005 2005 ABN Amro Global Generic Pharmaceutical Conference.
08/03/2005 Appendix 3C - On Market Buy-Back Notice
25/02/2005 Mayne expands UK Aseptic Manufacturing Services
23/02/2005 Supplementary Information Pack for 6 months to 31 December 2004
23/02/2005 Half Year Report
23/02/2005 Half Year Results Presentation
23/02/2005 Mayne reports 26% increase in half year earnings
22/02/2005 Final Director's Interest Notice (x 2)
22/02/2005 Retirement of Mr Peter Barnett and Mr Peter Mason
22/02/2005 Mayne Pharma and Pliva enter biogeneric partnership
21/02/2005 Appointment of additional Company Secretary
18/02/2005 Mayne receives English Court of Appeal decision for Epirubicin
16/02/2005 Mayne half year results webcast on 23 February 2005
10/02/2005 Mayne receives USFDA warning letter on ADE reporting
02/02/2005 Mayne Pharma and Strides broaden supply and distribution partnership with anti-infective products
31/01/2005 Completion of Port Macquarie Base Hospital sale
14/01/2005 JP Morgan Healthcare Conference presentation slides
10/01/2005 JP Morgan Healthcare Conference presentation and webcast